Search

Your search keyword '"ZHOU Shu"' showing total 14 results
Start Over Author "ZHOU Shu" Journal plos one
14 results on '"ZHOU Shu"'

10. Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer Treatment

Author

Yin, Juan-Juan, primary, Sharma, Sonali, additional, Shumyak, Stepan P., additional, Wang, Zhi-Xin, additional, Zhou, Zhi-Wei, additional, Zhang, Yangde, additional, Guo, Peixuan, additional, Li, Chen-Zhong, additional, Kanwar, Jagat R., additional, Yang, Tianxin, additional, Mohapatra, Shyam S., additional, Liu, Wanqing, additional, Duan, Wei, additional, Wang, Jian-Cheng, additional, Li, Qi, additional, Zhang, Xueji, additional, Tan, Jun, additional, Jia, Lee, additional, Liang, Jun, additional, Wei, Ming Q., additional, Li, Xiaotian, additional, and Zhou, Shu-Feng, additional

Published
2013
Full Text
View/download PDF

13. Proteomic Response to Acupuncture Treatment in Spontaneously Hypertensive Rats

Author

Lai, Xinsheng, primary, Wang, Jiayou, additional, Nabar, Neel R., additional, Pan, Sanqiang, additional, Tang, Chunzhi, additional, Huang, Yong, additional, Hao, Mufeng, additional, Yang, Zhonghua, additional, Ma, Chunmei, additional, Zhang, Jin, additional, Chew, Helen, additional, He, Zhenquan, additional, Yang, Junjun, additional, Su, Baogui, additional, Zhang, Jian, additional, Liang, Jun, additional, Sneed, Kevin B., additional, and Zhou, Shu-Feng, additional

Published
2012
Full Text
View/download PDF

14. Oxymatrine Improves Intestinal Epithelial Barrier Function Involving NF-κB-Mediated Signaling Pathway in CCl4-Induced Cirrhotic Rats.

Author

Wen, Jian-Bo, Zhu, Fang-Qing, Chen, Wei-Guo, Jiang, Li-Ping, Chen, Jie, Hu, Zhao-Peng, Huang, Yong-Jian, Zhou, Zhi-Wei, Wang, Gui-Liang, Lin, Hao, and Zhou, Shu-Feng

Subjects
INTESTINAL diseases, EPITHELIAL cells, CELLULAR signal transduction, CIRRHOSIS of the liver, LABORATORY rats, HEPATIC encephalopathy, DISEASES
Abstract

Accumulating evidence suggests that intestinal epithelial barrier dysfunction plays an important role in the pathogenesis of hepatic cirrhosis and its complications such as gastrointestinal injury and hepatic encephalopathy. To date, there is no cure for cirrhosis-associated intestinal mucosal lesion and ulcer. This study aimed to investigate the effect of oxymatrine on intestinal epithelial barrier function and the underlying mechanism in carbon tetrachloride (CCl4)-induced cirrhotic rats. Thirty CCl4-induced cirrhotic rats were randomly divided into treatment group, which received oxymatrine treatment (63 mg/kg), and non-treatment group, which received the same dose of 5% glucose solution (vehicle). The blank group (n = 10 healthy rats) received no treatment. Terminal ileal samples were collected for histopathological examination. The expression level of nuclear factor-κB (NF-κB) p65 in ileal tissue was evaluated by immunohistochemistry. The gene and protein expression levels of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) in ileal tissues were analyzed by reverse-transcriptase polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Additionally, plasma endotoxin level was determined. In comparison to the blank group, a significant alteration in the morphology of intestinal mucosal villi in the non-treatment group was observed. The intestinal mucosal villi were atrophic, shorter, and fractured, and inflammatory cells were infiltrated into the lamina propria and muscular layer. Besides, serious swell of villi and loose structure of mucous membrane were observed. Oxymatrine reversed the CCl4-induced histological changes and restored intestinal barrier integrity. Moreover, oxymatrine reduced the protein expression level of NF-κB p65, TNF-α, and IL-6, which were elevated in the vehicle-treated group. In addition, the serum endotoxin level was significantly decreased after oxymatrine treatment in CCl4-induced cirrhotic rats. The results indicate that oxymatrine improves intestinal barrier function via NF-κB-mediated signaling pathway and may be used as a new protecting agent for cirrhosis-associated intestinal mucosal damage. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results